Original ResearchPublished 12 October 2026Clinical characteristics, treatment patterns and long-term outcomes of warm and mixed autoimmune hemolytic anemia: insights from a real-world studyJunan Zhang · Yuan Li · Jiewen Qiu · Yizhou Zheng · Meili Ge · Fengkui Zhang · Jun Shi · Xin ZhaoFrontiers in Immunologydoi 10.3389/fimmu.2026.1931581
Systematic ReviewPublished 8 October 2026Treatment of idiopathic pulmonary hemosiderosis in children: a systematic reviewPengCheng Liu · ZhiChao LeiFrontiers in Pediatricsdoi 10.3389/fped.2026.1982437
Case ReportPublished 6 October 2026Case Report: Light chain amyloidosis in a patient with low-grade B-cell lymphomaAlex Matthaeus · David Thomas · Hakan R. TokaFrontiers in Nephrologydoi 10.3389/fneph.2026.1959759
Original ResearchPublished 3 September 2026Clinical phenotypes, endotypes, and biomarker profiles of immediate rituximab hypersensitivity reactions: a prospective pharmacovigilance studyNarapong Yotinnoratham · Wannada Laisuan · Kumutnart Chanprapaph · Silada Kanokrungsee · Chavachol Setthaudom · Supornchai Onpun · Pungjai Mongkolpathumrat · Supranee Buranapraditkun · Apinya Chungcharoenpanich · Nichapha Dechapaphapitak · Supa Oncham · Nattakirana Tongdee · Sananya Khamkaew · Ratchaya Lertnawapan · Jettanong KlaewsongkramFrontiers in Allergydoi 10.3389/falgy.2026.1903523
Case ReportPublished 28 August 2026Case report: Caplacizumab without plasma exchange for severe thrombotic thrombocytopenic purpuraSarah Maryon Hayes · Daniel F. Pease · Christine M. Wiese · Marshall MazepaFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1894135
Brief Research ReportPublished 4 August 2026Immunoglobulin replacement therapy in antineutrophil cytoplasmic antibody-associated vasculitis with rituximab-associated hypogammaglobulinemia: infection outcomes and disease course in a retrospective cohortMatthew Gross · Aditi Singh · Raj Roshan · Antoine Azar · Duvuru GeethaFrontiers in Nephrologydoi 10.3389/fneph.2026.1861999
Original ResearchPublished 17 July 2026Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort studyUlrich Pein · Klemens Budde · Lutz Liefeldt · Anja Gäckler · Rolf Weimer · Hristos Karakizlis · Claudia Sommerer · Louise Benning · Christine Kurschat · Dirk Stippel · Ana Harth · Julia Weinmann-Menke · Martina Koch · Birgit Kortus-Goetze · Stefan Reuter · Nils Lachmann · Anja MühlfeldFrontiers in Nephrologydoi 10.3389/fneph.2026.1899385
ReviewPublished 7 July 2026Post-transplant lymphoproliferative disorder after solid organ transplantation: a comprehensive reviewLina Patricia Vargas-Nieto · Nicolás David Santoyo-Sarmiento · Maria Ballesteros-García · Angie Tatiana Calderón-Vásquez · Álvaro Daniel Pinto-Rodriguez · Maria Gabriela Robayo-Romero · Valeria Cormane-Alfaro · Jorge Daza-BuitragoFrontiers in Transplantationdoi 10.3389/frtra.2026.1869288
ReviewPublished 2 July 2026Positioning rituximab in the therapeutic strategies for SLEChrysanthi Staveri · Stamatis-Nick C. LiossisFrontiers in Lupusdoi 10.3389/flupu.2026.1877692
Mini ReviewPublished 4 May 2026Postpartum acquired hemophilia A: immunopathogenesis, diagnostic challenges, and treatment with the CyDRi protocolÁgnes Szappanos · Hajnalka Andrikovics · Péter Varga · Mónika Fekete · Vince Fazekas-Pongor · Márk Lehoczki · Viktória Király · Beáta Vilimi · Gábor Mikala · Imre Bodó · Andrea CeglédiPathology and Oncology Researchdoi 10.3389/pore.2026.1612302
Case ReportPublished 13 April 2026Case Report: Pernicious anemia-associated pancytopenia responds to immunotherapyAlexander Krule · Carlos Murga-Zamalloa · Irum Khan · Ryan Sun · John G. QuigleyFrontiers in Hematologydoi 10.3389/frhem.2026.1733719
Case ReportPublished 23 February 2026Rapid response to obinutuzumab and venetoclax in patients with nephrotic syndrome related to CLL: a report of two casesEmin Abdullayev · Markus Bieringer · Anna Ossami Saidy · Sefer Elezcurtaj · Wolfgang Schneider · Bertram Glaß · Snjezana JanjetovicFrontiers in Hematologydoi 10.3389/frhem.2026.1776722
Musculoskeletal DisordersPublished 13 December 2023Screening practices, efficacy, safety and adherence to biologic therapies in a South African tertiary hospitalMohammed Awad Eltoum Ahmed · Christiaan Scott · Ayanda Gcelu · Jonel Steffen · Thuraya Isaacs · Bridget HodkinsonFrontiers in Musculoskeletal Disordersdoi 10.3389/fmscd.2023.1281548
